Impact of prior treatment on response to cell transfer therapy using selected TILs
| n (%)a | ORb | |||
|---|---|---|---|---|
| Total | CR | PR | ||
| All patients | 93 | 20 (22) | 32 (34) | 52 (56) |
| Prior treatment | ||||
| None | 5 (5) | 2 (40) | 1 (20) | 3 (60) |
| IL-2 | 77 (83) | 14 (18) | 28 (36) | 42 (54) |
| Chemotherapy | 40 (43) | 7 (18) | 16 (40) | 23 (58) |
| IFN | 52 (56) | 11 (21) | 17 (33) | 28 (54) |
| Anti-CTLA4 | 11 (12) | 5 (45) | 2 (18) | 7 (64) |
| IL-2+ chemotherapy | 37 (40) | 6 (16) | 16 (43) | 22 (59) |
| IL-2+ anti-CTLA4 | 8 (9) | 3 (38) | 1 (13) | 4 (50) |
| IL-2+ anti-CTLA4+ chemotherapy | 6 (7) | 2 (33) | 1 (17) | 3 (50) |